• In the second quarter of 2026, Herbalife Ltd. reported higher net sales of US$1,326.8 million year on year but moved to a net loss of US$26.3 million, while also announcing long‑time CFO John DeSimone will retire at the end of 2026, to be succeeded by Scott Schaefer.
• Despite the swing to a quarterly loss, Herbalife raised its full‑year 2026 net sales growth guidance and outlined a planned CFO transition that brings external e‑commerce and customer‑experience expertise into the finance leadership role.
• Next, we’ll examine how Herbalife’s improved full‑year sales guidance and upcoming CFO change might influence its existing investment narrative.

Find 51 companies with promising cash flow potential yet trading below their fair value.

Herbalife Investment Narrative Recap

To own Herbalife here, you need to believe its push toward a more digital, wellness focused model can translate modest sales growth into healthier long term economics, despite pressure on profitability and a leveraged balance sheet. The latest results do not appear to change the near term catalyst, which is evidence that revenue growth can translate into consistent earnings, or the key risk around profitability and debt, although the swing to a quarterly loss keeps that risk front of mind.

The most relevant update is Herbalife’s decision to raise full year 2026 net sales guidance to growth of 2.5% to 5.5% year on year, even after reporting a Q2 net loss of US$26.3 million. For a thesis that leans on gradual revenue growth and better cash generation, this guidance matters more than the upcoming CFO change, because it directly tests whether recent commercial initiatives can offset margin pressure and interest costs.

But while sales guidance is firmer, the combination of losses and high leverage still leaves Herbalife exposed in ways investors should be aware of if...

Herbalife's narrative projects $5.6 billion revenue and $317.3 million earnings by 2029. This requires 2.9% yearly revenue growth and about a $77.5 million earnings increase from $239.8 million today.

Uncover how Herbalife's forecasts yield a $18.33 fair value, a 46% upside to its current price.

Exploring Other Perspectives

The most pessimistic analysts were already assuming only about 2.8% annual revenue growth and earnings of roughly US$296.7 million by 2029, so if you are worried about mounting debt and limited flexibility, this new mix of higher sales and weaker profitability may strengthen that cautious view or prompt you to reassess how much downside you think is still priced in.

Explore 5 other fair value estimates on Herbalife - why the stock might be worth just $18.33!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Herbalife research is our analysis highlighting 2 key rewards and 3 important warning signs that could impact your investment decision.
• Our free Herbalife research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Herbalife's overall financial health at a glance.

Ready For A Different Approach?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Uncover the next big thing with 19 elite penny stocks that balance risk and reward.
• Outshine the giants: these 16 early-stage AI stocks could fund your retirement.
• AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.